Hamlet BioPharma schedules September digital investor meeting

Hamlet BioPharma AB has scheduled its monthly digital investor meeting for September 23, 2026, commencing at 12:00.

Participants can join the meeting through a provided Zoom link. The company has disseminated the access details for the virtual session.

CFO Jakob Testad and CEO Catharina Svanborg are available for further inquiries. This meeting is part of the company's ongoing engagement with its investor base.

Hamlet BioPharma is a Swedish pharmaceutical company focused on developing cancer treatments, particularly for prostate and colorectal cancer.